Lawmakers have focused on the high cost of diabetes drugs. The announcement will make state-branded insulin available two ...
LONDON, July 23 (Reuters) - The European Union's drug watchdog cast further doubt on recent studies suggesting a possible cancer risk with Sanofi-Aventis's widely-used Lantus diabetes drug. The ...
(Reuters) - Sanofi SA, whose top-selling Lantus helps diabetics control blood sugar levels, has filed a lawsuit accusing Eli Lilly and Co of infringing seven patents related to insulin and devices ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback